Medicine and Dentistry
Prostate Cancer
100%
Neoplasm
42%
Prostatectomy
27%
Gleason Score
18%
Disease
18%
Metastatic Carcinoma
16%
Immunohistochemistry
15%
Adenocarcinoma
13%
Prostate Adenocarcinoma
13%
Malignant Neoplasm
11%
Biopsy
10%
Clear Cell Renal Cell Carcinoma
8%
Hazard Ratio
8%
Carcinoma
8%
Prostate Tumor
8%
High-Grade Prostatic Intraepithelial Neoplasia
7%
Transcriptomics
7%
Needle Biopsy
6%
Androgen Receptor
6%
Morphology
6%
Small-Cell Carcinoma
6%
Cancer Cell
6%
Prostate Specific Antigen
6%
DNA Mismatch Repair
6%
Intraductal Carcinoma
6%
Gene Mutation
5%
Somatics
5%
Prostate Biopsy
5%
Biological Marker
5%
Phosphatase
5%
Tensin
5%
Androgen Deprivation Therapy
5%
Keyphrases
Prostate Cancer
59%
Tumor
18%
Radical Prostatectomy
16%
PTEN Loss
13%
Primary Prostate Cancer
11%
Prostatic Adenocarcinoma
10%
High Risk
8%
Confidence Interval
7%
Immunohistochemical Features
7%
Germ Cells
7%
Immunohistochemistry
6%
Hazard Ratio
6%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
6%
Metastasis
6%
Prostate Tumor
6%
Tissue Microarray
6%
Prostatectomy
5%
Small Cell Carcinoma
5%
Prostate Carcinoma
5%
High Grade Prostatic Intraepithelial Neoplasia (HGPIN)
5%
Clinical Pathological Characteristics
5%
BRCA2
5%
Prostate
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
10%
Gleason Score
10%
Germ Cell
8%
Germline
8%
Tissue Microarray
8%
Fluorescence in Situ Hybridization
6%
Gene Mutation
6%
Prevalence
6%
DNA Repair
6%
DNA Mismatch Repair
6%
Genetics
5%
Transcriptomics
5%
Androgen Receptor
5%
Morphology
5%
BRCA2
5%
P53
5%
Phosphatase
5%
Tensin
5%
Protein Expression
5%
Progression Free Survival
5%
Telomere
5%
